Dose clinical dosage of dexamethasone inhibits the effect of sugammadex in reversing rocuronium?
Not Applicable
- Conditions
- Not Applicable
- Registration Number
- KCT0001603
- Lead Sponsor
- Bundang CHA General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients undergoing laryngeal microscopic surgery or nasal bone reduction operation under general anesthesia
American Society of Anesthesiologists (ASA) physical status classification system of I-II
Aged 20-60 years
Exclusion Criteria
Difficult intubation was anticipated
If patients had a neuromuscular disorder that could impair neuromuscular block
Significant renal or hepatic dysfunction
A (family) history of malignant hyperthermia
Allergy to narcotics,neuromuscular blocking agents, or other medication used during general anesthesia
Receiving medications expected to interfere with the neuromuscular blocking agents
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the time from the start of sugammadex administration until recovery of the TOF ratio to 0.9.
- Secondary Outcome Measures
Name Time Method oxygen saturation;respiratory rate